Lv11
100 积分 2023-11-21 加入
Re-understanding of SERS for General and Standardized Quantitative Analysis
2小时前
待确认
Mitochondria-Specific Molecular Crosstalk between Ferroptosis and Apoptosis Revealed by In Situ Raman Spectroscopy
3小时前
已完结
Cost–effectiveness of pembrolizumab plus axitinib as first-line therapy for advanced renal cell carcinoma
29天前
已关闭
Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer
29天前
已完结
Cost–effectiveness analysis of pembrolizumab for patients with advanced esophageal cancer at PD-L1 combined positive score ≥10
29天前
已关闭
FrontlineBRAFTesting–Guided Treatment for Advanced Melanoma in the Era of Immunotherapies
29天前
已完结
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenocarcinoma in Japan
29天前
已完结
Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma
1个月前
已完结
Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan
1个月前
已完结
Cost-effectiveness analysis of an orphan drug tebentafusp in patients with metastatic uveal melanoma and a call for value-based pricing
1个月前
已完结
皖公网安备34019202002308
